The ACH was first outlined by John Hardy and David Allsopp, drawing on work led by Alison Goate from Hardy's group which had identified the first genetic mutations causing familial Alzheimer's disease – a missense mutation in the amyloid precursor protein on chromosome 21 identified in a UK family (V717I; the “London” mutation). Here, APP is linked to early-onset autosomal dominant Alzheimer disease.